Tumor Necrosis Factor (TNF) Inhibitor Drugs Market (By Product: Simponi/Simponi Aria, Remicade, Enbrel, Cimzia, Humira, Biosimilars; By Application: Psoriatic Arthritis, Crohn’s Disease, Rheumatoid Arthritis, Psoriasis, Juvenile Idiopathic Arthritis, Hidradenitis Suppurativa, Ulcerative Colitis, Ankylosing Spondylitis, Others; By Sales Channel: Online Pharmacies, Specialty Pharmacies, Hospital Pharmacies) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

Introduction

According to Acumen Research and Consulting, the global TNF Inhibitor Drugs market is forecasted to grow at striking CAGR around 0.6% over the forecast time frame and reach around US$ 41 billion by 2026.

TNF inhibitors or factor inhibitors of tumor necrosis are biological medicines extracted from human or animal tissue, most frequently used to prevent inflammating and the development of disease, through a suppression of the inflammatory substance, i.e. the necrosis factor of the tumor, in the body. It is mainly used for the therapy of multiple inflammatory diseases such as rheumatoid arthritis, psoriasis and inflammatory bowel disease. In addition to Adalimumab (Humira), Infliximab (Remicade), Certolizumab (Cimzia), etanercept (Enrel), and more, these TNF inhibitors that are currently approved for the therapy of different inflammatory circumstances.

The report provides analysis of global TNF Inhibitor Drugs market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.

Market Insights

New product launches, promising pipelines, increased autoimmune disease incidences and significantly increased customer awareness of the Tumor Necrosis Factor (TNF) are anticipated to drive development. TNF inhibitors are used to suppress TNF cytokine inflammation and, consequently, to treat autoimmune and inflammatory diseases like rheumatoid arthritis, psoriasis, Crohn's, and cancer, for example. TNF inhibitors are investigating the role of TNF in the therapy of metastatic melanomas and locally developed soft tissue sarcomas.

Biosimilars pose a direct inner danger to the biologics in TNF inhibitors markets. Loss of patent exclusivities in different areas paves the way. Moreover, the market has intensely rivaled the inhibitors of Interleukin (IL). In many clinical trials, IL inhibitors are shown to have enhanced safety and effectiveness profiles and to show superior outcomes. There has been a substantial paradigm shift in autoimmune disease therapy caused by targeted biodegradable action and the development of bio-similars. However, consumers are more likely to see beneficial impacts on the dynamics of market demand for cost efficient drugs with better safety and efficiency profiles.

Product Stance

In 2018, Humira was in charge of the product segment with almost half its income. In 2018, Humira produced USD 19.9 billion and remains one of the world's most popular pharmaceutical products. Even if Humira's patent expired in Europe in 2018, its exclusivity in the USA is maintained by 2023. The loss of patent exclusivity will probably lead to declined revenues, but it is expected that Humira will be the leading inhibitor of the TNF products by 2026. The biological wave presents a significant danger to biological products, backed by its cost-effectiveness and similar outcomes in head-to-head clinical trials. Several versions have been introduced of Humira, Enbrel, and Remicade. Erelzi, Inflectra / Remsima, Cyltezo and others are some of the main goods of this study.

Application Stance

Autoimmune disease is a major part of the market share, although other signs such as cancer are tested in the drugs. In 2018, rheumatoid arthritis resulted the application segment with an general income share of 17 percent. The segment of rheumatopoietic arthritis is motivated by a elevated therapy speed and product penetration. The most rapidly increasing application sections over the forecast period are psoriasis and psoriatic arthritis. Increasing disease prevalence, customer awareness backed by government and private awareness-raising campaigns and positive reimbursement policies drive the psoriasis market.

Sales Channel Stance

The biggest share of the market in hospitals in 2018 was motivated mainly by the elevated level of hospital turnover. More than retail pharmacies, most biologics and biomarks are marketed in specialized pharmacies. Specialty pharmacies offer one of the biggest benefits of providing tailored, disease-specific treatment plans for every patient and thereby addressing both economic limitations and achieving better results.

Regional Stance

Due to powerful commercial sales of TNF inhibitors in US, North America resulted the regional landscape in 2018. The existence of important producers, proactive governmental projects, favourable repayment policies and a big patient pool are among the other variables contributing to development. In the forecast period, Asia Pacific is expected to be one of the fastest-growing areas. Biosimilar trends are a major driver of national economic growth in the emerging markets, such as China, India and South Korea. Moreover, general economic development, better health infrastructure, higher disposable earnings and increased consumer awareness will probably lead to regional demand.

In the same vein, Europe was a significant share of the worldwide economy and was followed by North America as a result of the existence of a big, inflammatory geriatric population.

Market Segmentation

Global TNF Inhibitor Drugs Market, By Product

  • Simponi/Simponi Aria
  • Remicade
  • Enbrel
  • Cimzia
  • Humira
  • Biosimilars

Global TNF Inhibitor Drugs Market, By Application

  • Psoriatic Arthritis
  • Crohn’s Disease
  • Rheumatoid Arthritis
  • Psoriasis
  • Juvenile Idiopathic Arthritis
  • Hidradenitis Suppurativa
  • Ulcerative Colitis
  • Ankylosing Spondylitis
  • Others

Global TNF Inhibitor Drugs Market, By Sales Channel

  • Online Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies

Global TNF Inhibitor Drugs Market, By Geography

  • North America.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

The market research study on “Tumor Necrosis Factor (TNF) Inhibitor Drugs Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global TNF Inhibitor Drugs market segments with market dynamics and their impact. The report also covers basic technology development policies.

It offers an assessment of the recent industry trends for each sub-segment between 2015 and 2026, and anticipates income development at worldwide, regional and nation levels. For this research, ARC segmented the worldwide TNF Inhibitor Drugs market report on the grounds various segments.

Key Players & Strategies

Some of the key players are Amgen Inc.; AbbVie Inc.; Pfizer, Inc.; Novartis International AG; Johnson & Johnson Services, Inc.; UCB S.A.; and Merck & co., Inc. Competitive market dynamics arise through strategic initiatives, which include fusion and acquisitions, partnerships and joint ventures.

As regulatory processes become stricter and competitive, fresh products must have a major clinical benefit in terms of safety and efficacy or end-result over current products. This resulted to numerous head-to-head experiments between important market products, like Humira and Remicade, and fresh products or applicants for late-stage pipelines. Through comparative parameter assessment, these experiments determine the superiority of performance.

The sector market leaders have established themselves on the market and appreciate customer brand loyalty. These companies offer a broad variety of products and have a large worldwide distribution system. Small players, particularly in Asian emerging markets, also enter the market. However, the market penetration of fresh entrants will be reduced by strict legislative structure and high quality standards set by market leaders.


FAQ

Healthcare Drone Market (By Product Type: Rotary Blade, Fixed Wing, Hybrid; By Application: Search and Rescue, Transport/Delivery, Medical Care) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Healthcare drones provide medical care facilities for the people in a few minutes to bring blood, medicines, serum snake bite, birth control, and other resources to rural areas, which in some situations could be the difference between life and death. Market Insights Increased awareness of healthcare drones is likely to fuel dema

Metal Implants and Medical Alloys Market (By Type: Titanium, Stainless Steel, Cobalt Chrome, Others; By Application: Orthopedic Implants, Cardiovascular Implants, Dental Application, Craniomaxillofacial Impnats, Neurological Implants) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The Global Metal Implants and Medical Alloys Market size is expected to garner around US$ 19.5 Bn by 2026, growing at a CAGR of around 9.2% over the forecast period 2019 to 2026. Metal implants are the biomaterials that are used to place inside or on the surface of the body. These are basically made up of stainless steel, Cobalt Chrome (CoCr) alloys, Titanium (Ti), and Ti alloys are widely used in orthopedic i

Next Generation sequencing Market (By Products and Services: NGS Platforms & Related Products, NGS Services; By Application: Oncology, Reproductive Health, Clinical Investigation, Immune System Monitoring, Agriculture & Animal Research, Epidemiology & Drug Development, Consumer Genomics; By Technology: Whole Genome Sequencing, Targeted Sequencing & Resequencing, Whole Exome Sequencing; By End Users: Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other users) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The Global Next Generation Sequencing Market is expected to grow at a CAGR of around 18.7% over the forecast period 2019 to 2026 and poised to reach around US$ 20.4 Bn by 2026. Next Generation Sequencing (NGS) is a platform that enabled the sequencing of thousands to millions DNA molecules simultaneously. It is also known as the massively parallel sequencing technology. This sequencing helps in the various fie

Ultrasound Equipment Market (By Portability: Trolley/Cart-based, Compact, Handheld; By Application: Obstetrics/Gynecology, General Imaging, Vascular Applications, Cardiologic Applications, Orthopedic Applications, Urological Applications, Pain Management, Others; By Equipment Display: Black & White, Color; By Technology: Therapeutic, Diagnostic) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ultrasound equipment market is expected to grow at a CAGR of around 6.3% from 2019 to 2026 and expected to reach the market value of around US$ 10 Bn by 2026. Ultrasound is a medical imaging technology that uses sound waves to produce pictures of body’s inside part. It helps to diagnose swelling, pain, and infection in internal organs and to examine a baby in pregnant women. Ultrasound is also

Minimally Invasive Surgery Market (By Product: Handheld Instruments, Electrosurgical Instruments, Guiding Devices, Inflation Systems, Auxiliary Instruments, Cutter Instruments; By Application: Gastrointestinal Surgery, Cardiothoracic Surgery, Orthopedic Surgery, Gynecological Surgery, Cosmetic/Bariatric Surgery, Vascular Surgery, Urological Surgery, Others; By End User: Hospitals, Ambulatory Surgery Centers, Research Institutes) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global minimally invasive surgery market is expected to grow at a CAGR of around 9.6% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 33.8 Bn by 2026. Minimally invasive surgery uses techniques to operate with less incision or damage to the body than open surgery. Hence, it is associated with less pain, fewer postoperative complications, and short

Implantable Medical Devices Market (By Product: Dental Implants, Breast Implants, Orthopedic Implants, Cardiovascular Implants, Intraocular Lens, Others) - Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global implantable medical devices market is expected to grow at a CAGR of around 7.3% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 153.8 Bn by 2026. An implant is a medical device, manufactured to support or replace any damaged organs in the body, treat imperfections in normal body functions, or enhance the functioning of body organs. These can be implanted by

Cart Summary